Milagro Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
- Paid Up Capital ₹ 1.98 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 1347099.02%
- Profit Growth 520466.87%
- Ebitda 782687.86%
- Net Worth 2673343.67%
- Total Assets 461377.12%
About Milagro Life Sciences
Milagro Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2016 (Eight years and two months 16 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 1.98 M, as per Ministry of Corporate Affairs (MCA) records.
Mahendra Shinde and Shrikant Kachare serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2016PTC287957
-
Company No.
287957
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Nov 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Milagro Life Sciences Private Limited offer?
Milagro Life Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Eye Drops, Pain Relief Drugs & Pharmaceuticals, Diclofenac.
Who are the key members and board of directors at Milagro Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Shinde
|
Director | 22-Aug-2023 | Current |
|
Shrikant Kachare
|
Director | 10-Aug-2023 | Current |
Financial Performance of Milagro Life Sciences.
Milagro Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1347099.02% increase. The company also saw a substantial improvement in profitability, with a 520466.87% increase in profit. The company's net worth Soared by an impressive increase of 2673343.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Milagro Life Sciences?
In 2023, Milagro Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Milagro Life Sciences?
Unlock and access historical data on people associated with Milagro Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Milagro Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milagro Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
